You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mCSPC

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

Not yet recruiting
  • Metastatic Castrate-sensitive Prostate Cancer
  • Lakewood, Colorado
  • +5 more
May 23, 2023

Learn About Novel Hormonal Therapies for Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Nov 21, 2023

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Prostate Cancer, mCRPC, mCSPC Trial in United States (PRL-02, Prednisone, dexamethasone)

Recruiting
  • Prostate Cancer
  • +2 more
  • Jeffersonville, Indiana
  • +7 more
Aug 17, 2022

Metastatic Castration-sensitive Prostate Cancer Trial in Osaka-sayama (Apalutamide)

Recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Hospital
Dec 6, 2020

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Called AWARENESS Using Data From Alberta to Observe Treatment

Active, not recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • ADT (Eligard®*) with or without treatment intensification
  • Multiple Locations, Alberta, Canada
  • +1 more
Aug 1, 2022

Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-Sensitive Prostate Cancer
  • Tucson, Arizona
  • +192 more
Nov 6, 2023

Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Castration-Sensitive Prostate Cancer
  • Shanghai, Shanghai, China
  • +1 more
Feb 4, 2023

Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Birmingham, Alabama
  • +306 more
Jan 18, 2023

Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)

Recruiting
  • Metastatic Castrate Sensitive Prostate Cancer
  • Homewood, Alabama
  • +439 more
Jan 17, 2023

Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)

Active, not recruiting
  • Prostate Cancer
  • +2 more
  • PROSTVAC-V
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022

Metastatic Prostate Cancer Trial in Salt Lake City (dietary supplement, other, behavioral)

Not yet recruiting
  • Metastatic Prostate Cancer
  • creatine monohydrate
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Oct 30, 2023

Patterns and Associated Clinical Outcomes in Metastatic

Completed
  • Metastatic Castration-resistant Prostates Cancer
    • Valledupar, Colombia
    • +29 more
    Jan 16, 2023

    Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

    Not yet recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 8, 2023

    Prostate Cancer, Prostate Carcinoma, Metastatic Prostate Cancer Trial (Olaparib tablet, Abiraterone acetate, Prednisone tablet)

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Olaparib tablet
    • +2 more
    • (no location specified)
    Dec 7, 2021

    Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Phase I and Phase II: LAE001/prednisone + afuresertib
    • Tucson, Arizona
    • +16 more
    Nov 30, 2022

    Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

    Recruiting
    • Metastatic Prostate Cancer
    • Prostate Adenocarcinoma
    • Tucson, Arizona
    • +259 more
    Oct 19, 2022

    Physical Function During ARSI Treatment

    Recruiting
    • Advanced Prostate Carcinoma
    • androgen receptor signaling inhibitors
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Nov 8, 2022

    CTC Immune Checkpoint

    Completed
    • Prostate Cancer
    • CTC biomarker expression prevalence
    • Durham, North Carolina
      Duke University Medical Center
    Jul 8, 2019

    Prostate Cancer Trial in United States (EC1169, EC0652)

    Completed
    • Prostate Cancer
    • Scottsdale, Arizona
    • +5 more
    Feb 6, 2019